Skip to content

LivaNova LIVN Total debt

Total debt at other companies

Haemonetics logo
HaemoneticsHAE
$1.27B-0.7%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$821.56M+0.5%
Abbott logo
AbbottABT
Medtronic logo
MedtronicMDT
ResMed logo
ResMedRMD
Stryker logo
StrykerSYK

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Calculated from LivaNova’s reported figures.

Plus components not separately reported this period.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's total debt?
LivaNova (LIVN) reported total debt of $340.94M in Q1 2026.
How has LivaNova's total debt changed year-over-year?
LivaNova's total debt decreased by 49.7% year-over-year, from $677.21M to $340.94M.
What is the long-term trend for LivaNova's total debt?
Over 5 years (2020 to 2025), LivaNova's total debt has grown at a -9.3% compound annual growth rate (CAGR), from $704.17M to $433.18M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.